Search Results

You are looking at 1 - 1 of 1 items for :

  • Author: Aitor Ibarzábal-Gil x
Clear All Modify Search
Elena Gálvez-Sirvent Department of Orthopaedic Surgery, ‘Infanta Elena’ University Hospital, Valdemoro, Madrid, Spain

Search for other papers by Elena Gálvez-Sirvent in
Google Scholar
PubMed
Close
,
Aitor Ibarzábal-Gil Department of Orthopaedic Surgery, ‘La Paz’ University Hospital-IdiPaz, Madrid, Spain

Search for other papers by Aitor Ibarzábal-Gil in
Google Scholar
PubMed
Close
, and
E. Carlos Rodríguez-Merchán Department of Orthopaedic Surgery, ‘La Paz’ University Hospital-IdiPaz, Madrid, Spain

Search for other papers by E. Carlos Rodríguez-Merchán in
Google Scholar
PubMed
Close

  • In aseptic tibial diaphyseal nonunions after failed conservative treatment, the recommended treatment is a reamed intramedullary (IM) nail.

  • Typically, when an aseptic tibial nonunion previously treated with an IM nail is found, it is advisable to change the previous IM nail for a larger diameter reamed and locked IM nail (the rate of success of renailing is around 90%).

  • A second change after an IM nail failure is also a good option, especially if bone healing has progressed after the first change.

  • Fibular osteotomy is not routinely advised; it is only recommended when it interferes with the nonunion site.

  • In delayed unions before 24 weeks, IM nail dynamization can be performed as a less invasive option before deciding on a nail change.

  • If there is a bone defect, a bone graft must be recommended, with the gold standard being the autologous iliac crest bone graft (AICBG).

  • A reamer-irrigator-aspirator (RIA) system might also obtain a bone autograft that is comparable to AICBG.

  • Although the size of the bone defect suitable to perform bone transport techniques is a controversial issue, we believe that such techniques can be considered in bone defects > 3 cm.

  • Non-invasive therapies and biologic therapies could be applied in isolation for patients with high surgical risk, or could be used as adjuvants to the aforementioned surgical treatments.

Cite this article: EFORT Open Rev 2020;5:835-844. DOI: 10.1302/2058-5241.5.190077

Open access